1359948-56-3Relevant articles and documents
Synthesis and structure-activity relationship of C-phenyl D-glucitol (TP0454614) derivatives as selective sodium-dependent glucose cotransporter 1 (SGLT1) inhibitors
Hamada, Makoto,Kakinuma, Hiroyuki,Kawabe, Kenichi,Kawamura, Madoka,Kimura, Kayo,Kobashi, Yohei,Koretsune, Hiroko,Kuroda, Shoichi,Okumura-Kitajima, Lisa,Shimizu, Yuki,Shiozawa, Fumiyasu,Yamamoto, Koji
, p. 635 - 652 (2020/07/30)
Sodium-glucose cotransporter 1 (SGLT1) is the primary transporter for glucose absorption from the gastrointestinal tract. While C-phenyl D-glucitol derivative SGL5213 has been reported to be a potent intestinal SGLT1 inhibitor for use in the treatment of type 2 diabetes, no SGLT1 selectivity was found in vitro (IC50 29 nM for hSGLT1 and 20 nM for hSGLT2). In this study we found a new method of synthesizing key intermediates 12 by a one-pot three-component condensation reaction and discovered C-phenyl D-glucitol 41j (TP0454614), which has >40-fold SGLT1 selectivity in vitro (IC50 26 nM for hSGLT1 and 1101 nM for hSGLT2). The results of our study have provided new insights into the structure-activity relationships (SARs) of the SGLT1 selectivity of C-glucitol derivatives.